Fintel reports that on November 18, 2025, B of A Securities maintained coverage of Werewolf Therapeutics (NasdaqGS:HOWL) with a Buy recommendation. Analyst Price Forecast Suggests 602.63% Upside As of ...
Click to share on X (Opens in new window) X Click to share on Facebook (Opens in new window) Facebook It’s been a rocky road to The Wolf Among Us 2, but it looks like an end could be in sight.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback